Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway

Cancer Letters

Volumn 258, Issue 2, 2007, Pages 199-207

  Ye, Mao ^a,c   Luo, Xiangjian ^a   Li, Lili ^a   Shi, Ying ^a   Tan, Ming ^a   Weng, Xinxian ^a   Li, Wei ^a   Liu, Jikai ^b   Cao, Ya ^a  

^a Central South University   (China)

^b KUNMING INSTITUTE OF BOTANY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; ERK1 2; ERK5; Grifolin

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2D; CYCLIN E; GRIFOLIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; UNCLASSIFIED DRUG;

ALBATRELLUS CONFLUENS; ANALYTIC METHOD; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MUSHROOM; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

AGARICALES; ANTINEOPLASTIC AGENTS; BIOLOGICAL PRODUCTS; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; G1 PHASE; GENE EXPRESSION; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TERPENES;

ALBATRELLUS CONFLUENS; BASIDIOMYCOTA;

EID: 36048952664     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.09.001     Document Type: Article

References (27)

1. Poindessous V., Koeppel F., Raymond E., Comisso M., Waters S.J., and Larsen A.K. Marked activity of irofulven toward human carcinoma cells: comparison with cisplatin and ecteinascidin. Clin. Cancer Res. 9 (2003) 2817-2825
2. Samanta A.K., Huang H.J., Bast Jr. R.C., and Liao W.S. Overexpression of MEKK3 confers resistance to apoptosis through activation of NFkappaB. J. Biol. Chem. 279 (2004) 7576-7583
3. Ellinger-Ziegelbauer H., Brown K., Kelly K., and Siebenlist U. Direct activation of the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by an inducible mitogen-activated protein Kinase/ERK kinase kinase 3 (MEKK) derivative. J. Biol. Chem. 272 (1997) 2668-2674
4. Zhou G., Bao Z.Q., and Dixon J.E. Components of a new human protein kinase signal transduction pathway. J. Biol. Chem. 270 (1995) 12665-12669
5. Chao T.H., Hayashi M., Tapping R.I., Kato Y., and Lee J.D. MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway. J. Biol. Chem. 274 (1999) 36035-36038
6. Zhang W., and Liu H.T. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 12 (2002) 9-18
7. Hoshino R., Tanimura S., Watanabe K., Kataoka T., and Kohno M. Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated: up-regulation of p27(Kip1). J. Biol. Chem. 276 (2001) 2686-2692
8. Sutter A.P., Maaser K., Hopfner M., Huether A., Schuppan D., and Scherubl H. Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor. J. Hepatol. 43 (2005) 808-816
9. Squires M.S., Nixon P.M., and Cook S.J. Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1. Biochem. J. 366 (2002) 673-680
10. Wilkinson M.G., and Millar J.B. Control of the eukaryotic cell cycle by MAP kinase signaling pathways. FASEB J. 14 (2000) 2147-2157
11. Ding Z.H., Dong Z.J., and Liu J.K. Albaconol, a novel prenylated resorcinol (=Benzene-1,3-diol) from Basidiomycetes Albatrellus confluens. Helv. Chim. Acta 84 (2001) 259-262
12. Hirata Y., and Nakanishi K. Grifolin, an antibiotic from a basidiomycete. J. Biol. Chem. 184 (1950) 135-143
13. Sugiyama K., Kawagishi H., Tanaka A., Saeki S., Yoshida S., Sakamoto H., and Ishiguro Y. Isolation of plasma cholesterol-lowering components from ningyotake (Polyporus confluens) mushroom. J. Nutr. Sci. Vitaminol. (Tokyo) 38 (1992) 335-342
14. Nukata M., Hashimoto T., Yamamoto I., Iwasaki N., Tanaka M., and Asakawa Y. Neogrifolin derivatives possessing anti-oxidative activity from the mushroom Albatrellus ovinus. Phytochemistry 59 (2002) 731-737
15. Iwata N., Wang N., Yao X., and Kitanaka S. Structures and histamine release inhibitory effects of prenylated orcinol derivatives from Rhododendron dauricum. J. Nat. Prod. 67 (2004) 1106-1109
16. Yu M.C., and Yuan J.M. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12 (2002) 421-429
17. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118 (2006) 3030-3044
18. Sun L.M., Li C.I., Huang E.Y., and Vaughan T.L. Survival differences by race in nasopharyngeal carcinoma. Am. J. Epidemiol. 165 (2007) 271-278
19. Ye M., Liu J.K., Lu Z.X., Zhao Y., Liu S.F., Li L.L., Tan M., Weng X.X., Li W., and Cao Y. Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, inhibits tumor cell growth by inducing apoptosis in vitro. FEBS Lett. 579 (2005) 3437-3443
20. Dolci S., Pellegrini M., Di Agostino S., Geremia R., and Rossi P. Signaling through extracellular signal-regulated kinase is required for spermatogonial proliferative response to stem cell factor. J. Biol. Chem. 276 (2001) 40225-40233
21. Hauck L., Hansmann G., Dietz R., and von Harsdorf R. Inhibition of hypoxia-induced apoptosis by modulation of retinoblastoma protein-dependent signaling in cardiomyocytes. Circ. Res. 91 (2002) 782-789
22. Ishikawa Y., and Kitamura M. Dual potential of extracellular signal-regulated kinase for the control of cell survival. Biochem. Biophys. Res. Commun. 264 (1999) 696-701
23. Wang S.S., Guan Z.Z., Xiang Y.Q., Wang B., Lin T.Y., Jiang W.Q., Zhang L., Zhang H.Z., and Hou J.H. Significance of EGFR and p-ERK expression in nasopharyngeal carcinoma. Zhonghua Zhong Liu Za Zhi 28 (2006) 28-31
24. Esparis-Ogando A., Diaz-Rodriguez E., Montero J.C., Yuste L., Crespo P., and Pandiella A. Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2. Mol. Cell. Biol. 22 (2002) 270-285
25. Mehta P.B., Jenkins B.L., McCarthy L., Thilak L., Robson C.N., Neal D.E., and Leung H.Y. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. Oncogene 22 (2003) 1381-1389
26. Kato Y., Tapping R.I., Huang S., Watson M.H., Ulevitch R.J., and Lee J.D. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 395 (1998) 713-716
27. Stewart Z.A., Westfall M.D., and Pietenpol J.A. Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol. Sci. 24 (2003) 139-145